Overview

This trial is active, not recruiting.

Condition type 1 diabetes
Treatment carecoach mobile application to assist in diabetes management
Phase phase 1
Sponsor University of California, San Francisco
Start date October 2013
End date June 2015
Trial size 60 participants
Trial identifier NCT01938807, UCSF 12-09213

Summary

Despite multidisciplinary care and advancements in therapeutics and technology, health outcomes remain suboptimal in pediatric diabetes centers world-wide. A major contributor to poor outcomes is suboptimal diabetes management in pediatric patients and their families. The premise of this research project is that patients and families do not have adequate resources to meet the level of diabetes management that translates to better outcomes. Therefore, we will give them a valuable tool to improve their overall management. The tool is CareCoach.

Research shows that enhancing communication and partnership among patients, parents, and providers is especially critical for optimal outcomes in pediatric diabetes. Communication gaps and conflict can complicate the already complex provider-patient interactions and daily management. We have therefore designed, refined, and made available to consumers a new mobile-based intervention, CareCoach, to improve communication; build trust among providers, patients and parents; and increase overall satisfaction with the quality of diabetes care. This web/mobile application is designed to help patients unobtrusively audiorecord their clinical encounters, track their medical consults and treatment plans, review information from past visits, create visit discussion guides, and track adherence to medication and dosing schedules. In addition, because mobile-based applications are inexpensive to administer, portable, and available at all times of day, CareCoach holds great promise for communication coaching and contributing to improved diabetes management.

We hypothesize that CareCoach will improve patient-parent-provider communications, build patient-parent-provider trust, and increase overall satisfaction with clinical interactions in a sample of children with type 1 diabetes and their parents. These improvements will lead to significant gains in diabetes management, setting the stage for optimal health outcomes. To test the effectiveness of CareCoach, we will conduct a randomized controlled trial comparing the CareCoach intervention to standard care in a sample of 60 children with type 1 diabetes and their parents.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification safety/efficacy study
Intervention model crossover assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
The intervention group receives the CareCoach mobile application
carecoach mobile application to assist in diabetes management
(Active Comparator)
The control group receives standard care.
carecoach mobile application to assist in diabetes management

Primary Outcomes

Measure
Diabetes Management
time frame: 6 months post-baseline

Secondary Outcomes

Measure
Hemoglobin A1c
time frame: 6 months post-baseline

Eligibility Criteria

Male or female participants from 7 years up to 12 years old.

Inclusion Criteria: - parent of a child with diagnosis of type 1 diabetes for at least one year - parent of a child with type 1 diabetes between the ages of 7-12 - provide informed consent in English - have access to the internet from home Exclusion Criteria: - no access to the internet - shorter duration of type 1 diabetes than one year

Additional Information

Official title Audio Health Engagement Analysis in Diabetes: The AHEAD Study
Principal investigator Diana Naranjo, PhD
Trial information was received from ClinicalTrials.gov and was last updated in October 2014.
Information provided to ClinicalTrials.gov by University of California, San Francisco.